Clinical Trials Directory

Trials / Completed

CompletedNCT04446884

Treatment of Stress Urinary Incontinence in Women With Autologous Adipose-derived Mesenchymal Stem Cells

Treatment of Stress Urinary Incontinence in Women With Autologous Adipose-derived Mesenchymal Stem Cells Mixed With Collagen Gel

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus · Other Government
Sex
Female
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Treatment of women with stress urinary incontinence using injection of autologous adipose-derived mesenchymal stem cells mixed with collagen gel

Detailed description

During the implementation of the project, method for the treatment of women stress urinary incontinence using injection of autologous adipose-derived mesenchymal stem cells mixed with collagen was developed. Effectiveness of MSCs is due to the following: * the ability of MSCs to stimulate tissue regeneration * positive results of preclinical studies of the method of treatment of stress urinary incontinence (SUI) in animals (female rats). After gynecological examination, diagnosis of SUI, MSCs were isolated from adipose tissue, cultured and then transplanted back to directly under mucosa of urethra by three point injection in one third distal from the urethral neck at 3, 6 and 9 o'clock and to the paraurethral area. Injected volume was 3 ml per patient. For injection MSCs (6\*10\^6 cells) were mixed with collagen solution (3,5% w\|w). Follow up patients monitoring was mperformed at 2, 4, 6 and 12 months after injection.

Conditions

Interventions

TypeNameDescription
BIOLOGICALAutologous adipose-derived mesenchymal stem cellsAutologous adipose-derived mesenchymal stem cells mixed with collagen solution
OTHERStandard treatment according to the Clinical protocolsStandard treatment according to the Clinical protocols

Timeline

Start date
2018-03-01
Primary completion
2019-12-31
Completion
2019-12-31
First posted
2020-06-25
Last updated
2020-06-25

Locations

1 site across 1 country: Belarus

Source: ClinicalTrials.gov record NCT04446884. Inclusion in this directory is not an endorsement.